, strategies for
revascularization, medical, endovascular, and surgical
management, nonrevascularization treatments, amputations, postprocedural care, and surveillance of
patients with CLTI. Since important studies expected
to provide level 1 evidence on management of CLTI
are still being conducted in the U.S.3 and in England,4
only nine recommendations are strong (Grade I),
supported by a high level (A) of evidence. Still, the